An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer (CheckMate 577)

November 4, 2025 updated by: Bristol-Myers Squibb

A Randomized, Multicenter, Double Blind, Phase III Study of Adjuvant Nivolumab or Placebo in Subjects With Resected Esophageal, or Gastroesophageal Junction Cancer

The primary purpose of this study is to determine whether Nivolumab will improve disease-free survival compared with placebo.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

794

Phase

  • Phase 3

Expanded Access

No longer available outside the clinical trial. See expanded access record.

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Buenos Aires, Argentina, 1093 AAS
        • Local Institution - 0198
      • CABA, Argentina, 1426
        • Local Institution - 0133
      • Córdoba, Argentina, X5006HBF
        • Local Institution - 0112
    • Buenos Aires
      • Capital Federal, Buenos Aires, Argentina, 1264
        • Local Institution - 0050
      • Capital Federal, Buenos Aires, Argentina, 1280
        • Local Institution - 0152
    • Distrito Federal
      • Ciudad Autonoma Buenos Aires, Distrito Federal, Argentina, 1118
        • Local Institution - 0164
    • Río Negro Province
      • Viedma, Río Negro Province, Argentina, 8500
        • Local Institution - 0207
    • Santa Fe Province
      • Rosario, Santa Fe Province, Argentina, 2000
        • Local Institution - 0208
    • Tucumán Province
      • San Miguel de Tucumán, Tucumán Province, Argentina, 4000
        • Local Institution - 0051
      • Hobart, Australia, 7000
        • Local Institution - 0099
    • New South Wales
      • Blacktown, New South Wales, Australia, 2148
        • Local Institution - 0200
      • Gosford, New South Wales, Australia, 2250
        • Local Institution - 0098
      • Kanwal, New South Wales, Australia, 2263
        • Local Institution - 0140
      • St Leonards, New South Wales, Australia, 2065
        • Local Institution - 0074
      • Tamworth, New South Wales, Australia, 2340
        • Local Institution - 0075
    • Queensland
      • Brisbane, Queensland, Australia, 4102
        • Local Institution - 0237
    • South Australia
      • Adelaide, South Australia, Australia, 5000
        • Local Institution - 0123
    • Victoria
      • Clayton, Victoria, Australia, 3168
        • Local Institution - 0072
    • Western Australia
      • Perth, Western Australia, Australia, 6150
        • Local Institution - 0156
      • Brussels, Belgium, 1200
        • Local Institution - 0035
      • Edegem, Belgium, 2650
        • Local Institution - 0037
      • Ghent, Belgium, 9000
        • Local Institution - 0086
      • Leuven, Belgium, 3000
        • Local Institution - 0034
      • Liège, Belgium, 4000
        • Local Institution - 0036
      • Namur, Belgium, 5000
        • Local Institution - 0087
      • Rio de Janeiro, Brazil, 22793-080
        • Local Institution - 0065
      • Salvador, Brazil
        • Local Institution - 0064
      • São Paulo, Brazil, 01246-000
        • Local Institution - 0062
      • São Paulo, Brazil, 01308-050
        • Local Institution - 0063
    • Federal District
      • Brasília, Federal District, Brazil, 70200-730
        • Local Institution - 0095
    • Minas Gerais
      • Belo Horizonte, Minas Gerais, Brazil, 30130-090
        • Local Institution - 0096
    • Paraná
      • Curitiba, Paraná, Brazil, 81520-060
        • Local Institution - 0221
    • Rio Grande do Sul
      • Ijuí, Rio Grande do Sul, Brazil, 98700-000
        • Local Institution - 0059
      • Porto Alegre, Rio Grande do Sul, Brazil, 90610-000
        • Local Institution - 0060
    • Santa Catarina
      • Itacorubi, Florianopolis, Santa Catarina, Brazil, 88034
        • Local Institution - 0223
    • São Paulo
      • Barretos, São Paulo, Brazil, 14780-070
        • Local Institution - 0061
      • Sao Jose de Rio Preto, São Paulo, Brazil, 15091-000
        • Local Institution - 0222
    • Alberta
      • Edmonton, Alberta, Canada, T6G 1Z2
        • Local Institution - 0129
    • British Columbia
      • Vancouver, British Columbia, Canada, V5Z 4E6
        • Local Institution - 0093
    • Nova Scotia
      • Halifax, Nova Scotia, Canada, B3H 1V7
        • Local Institution - 0092
    • Ontario
      • London, Ontario, Canada, N6A 4L6
        • Local Institution - 0094
      • Ottawa, Ontario, Canada, K1H 8L6
        • Local Institution - 0091
      • Toronto, Ontario, Canada, M5G 2M9
        • Local Institution - 0110
    • Quebec
      • Montreal, Quebec, Canada, H4A 3J1
        • Local Institution - 0134
      • Québec, Quebec, Canada, G1R 2J6
        • Local Institution - 0109
      • Trois-Rivières, Quebec, Canada, G8Z 3R9
        • Local Institution - 0214
      • Shanghai, China, 200032
        • Local Institution - 0232
      • Tianjin, China, 300060
        • Local Institution - 0228
    • Beijing Municipality
      • Beijing, Beijing Municipality, China, 100142
        • Local Institution - 0240
    • Fujian
      • Fuzhou, Fujian, China, 350014
        • Local Institution - 0234
    • Shanghai Municipality
      • Shanghai, Shanghai Municipality, China, 200030
        • Local Institution - 0227
      • Shanghai, Shanghai Municipality, China, 200032
        • Local Institution - 0239
    • Zhejiang
      • Hangzhou, Zhejiang, China, 310003
        • Local Institution - 0230
      • Hangzhou, Zhejiang, China, 310022
        • Local Institution - 0238
      • Linhai, Zhejiang, China, 317000
        • Local Institution - 0233
      • Brno, Czechia, 656 53
        • Local Institution - 0031
      • Hradec Králové, Czechia, 500 05
        • Local Institution - 0029
      • Olomouc, Czechia, 779 00
        • Local Institution - 0030
    • Central Jutland
      • Aarhus N, Central Jutland, Denmark, 8200
        • Local Institution - 0166
      • Avignon Cedes 9, France, 84918
        • Local Institution - 0215
      • Dijon, France, 21079
        • Local Institution - 0121
      • Lille, France, 59037
        • Local Institution - 0117
      • Paris, France, 75012
        • Local Institution - 0119
      • Pessac, France, 33604
        • Local Institution - 0120
      • Pierre-Bénite, France, 69495
        • Local Institution - 0118
      • Rennes, France, 35033
        • Local Institution - 0132
      • Rouen, France, 76000
        • Local Institution - 0149
      • Toulouse, France, 31403
        • Local Institution - 0148
      • Berlin, Germany, D-13353
        • Local Institution - 0006
      • Cologne, Germany, 50937
        • Local Institution - 0003
      • Essen, Germany, 45136
        • Local Institution - 0008
      • Hamburg, Germany, 20251
        • Local Institution - 0007
      • Marburg, Germany, 35043
        • Local Institution - 0017
      • Munich, Germany, 81675
        • Local Institution - 0005
      • Tübingen, Germany, 72076
        • Local Institution - 0011
    • Rhineland-Palatinate
      • Mainz, Rhineland-Palatinate, Germany, 55131
        • Local Institution - 0001
      • Hong Kong, Hong Kong
        • Local Institution - 0225
      • Budapest, Hungary, 1097
        • Local Institution - 0053
      • Budapest, Hungary, 1122
        • Local Institution - 0224
      • Debrecen, Hungary
        • Local Institution - 0052
      • Kaposvár, Hungary, 7400
        • Local Institution - 0057
      • Dublin, Ireland, 9
        • Local Institution - 0040
      • Galway, Ireland
        • Local Institution - 0038
    • CORK
      • Wilton, CORK, Ireland
        • Local Institution - 0039
      • Haifa, Israel, 31096
        • Local Institution - 0146
      • Jerusalem, Israel, 91120
        • Local Institution - 0144
      • Petah Tikva, Israel, 49100
        • Local Institution - 0143
      • Ramat Gan, Israel, 52621
        • Local Institution - 0145
      • Tel Aviv, Israel, 64239
        • Local Institution - 0142
      • Bergamo, Italy, 24127
        • Local Institution - 0105
      • Milan, Italy, 20133
        • Local Institution - 0104
      • Milan, Italy, 20097
        • Local Institution - 0137
      • Reggio Emilia, Italy, 42100
        • Local Institution - 0106
      • Roma, Italy, 00168
        • Local Institution - 0107
      • Fukuoka, Japan, 8111395
        • Local Institution - 0194
      • Kita-gun, Japan, 7610793
        • Local Institution - 0181
    • Akita
      • Akita, Akita, Japan, 0108543
        • Local Institution - 0173
    • Chiba
      • Chiba, Chiba, Japan, 2608677
        • Local Institution - 0180
    • Fukuoka
      • Fukuoka, Fukuoka, Japan, 8128582
        • Local Institution - 0187
    • Gifu
      • Gifu, Gifu, Japan, 5011194
        • Local Institution - 0189
    • Hiroshima
      • Hiroshima, Hiroshima, Japan, 7348551
        • Local Institution - 0183
    • Hokkaido
      • Sapporo, Hokkaido, Japan, 0030027
        • Local Institution - 0192
      • Sapporo, Hokkaido, Japan, 0608648
        • Local Institution - 0196
    • Kagoshima-ken
      • Kagoshima, Kagoshima-ken, Japan, 8908520
        • Local Institution - 0191
    • Kumamoto
      • Kumamoto, Kumamoto, Japan, 8608556
        • Local Institution - 0184
    • Miyagi
      • Sendai, Miyagi, Japan, 9808574
        • Local Institution - 0188
    • Osaka
      • Sayama, Osaka, Japan, 589-8511
        • Local Institution - 0182
      • Suita-shi, Osaka, Japan, 565-0871
        • Local Institution - 0185
    • Saitama
      • Kitaadachi-gun, Saitama, Japan, 3620806
        • Local Institution - 0186
    • Tokyo
      • Chuo-ku, Tokyo, Japan, 1040045
        • Local Institution - 0172
      • Koto-ku, Tokyo, Japan, 1358550
        • Local Institution - 0190
      • Minato-ku, Tokyo, Japan, 1058470
        • Local Institution - 0174
      • Shinjuku-ku, Tokyo, Japan, 1600023
        • Local Institution - 0193
      • Shinjuuku-ku, Tokyo, Japan, 1608582
        • Local Institution - 0204
      • Aguascalientes, Mexico, 20230
        • Local Institution - 0154
      • Distrito Federal, Mexico, 14080
        • Local Institution - 0084
      • Mexico City, Mexico, 06760
        • Local Institution - 0168
    • Chiapas
      • Tuxtla Gutiérrez, Chiapas, Mexico, 29038
        • Local Institution - 0212
    • Distrito Federal C.p.
      • Tlalpan, Distrito Federal C.p., Mexico, 14000
        • Local Institution - 0085
    • Guanajuato
      • Leon, Guanajato, Guanajuato, Mexico, 37000
        • Local Institution - 0127
      • Groningen, Netherlands, 9713 AP
        • Local Institution - 0042
      • Maastrict, Netherlands, 6229 HX
        • Local Institution - 0043
    • North Holland
      • Amsterdam, North Holland, Netherlands, 1066 CX
        • Local Institution - 0089
      • Callao, Peru, 02
        • Local Institution - 0195
      • Lima, Peru, 34
        • Local Institution - 0162
      • Lima, Peru, LIMA 31
        • Local Institution - 0141
      • Lima, Peru, LIMA 41
        • Local Institution - 0088
      • Gliwice, Poland, 44-101
        • Local Institution - 0083
      • Krakow, Poland, 31-202
        • Local Institution - 0138
      • Lublin, Poland, 20-081
        • Local Institution - 0139
      • Poznan, Poland, 60-780
        • Local Institution - 0082
      • Warsaw, Poland, 02-781
        • Local Institution - 0081
      • San Juan, Puerto Rico, 00927
        • Local Institution - 0097
      • Baia Mare, Romania, 430295
        • Local Institution - 0167
      • Bucharest, Romania, 022328
        • Local Institution - 0163
      • Bucharest, Romania, 021389
        • Local Institution - 0197
      • Cluj-Napoca, Romania, 400352
        • Local Institution - 0103
      • Craiova, Romania, 200347
        • Local Institution - 0028
      • Floreşti, Romania, 407280
        • Local Institution - 0135
      • Cheboksary, Russia, 428020
        • Local Institution - 0213
      • Moscow, Russia, 115478
        • Local Institution - 0125
      • Saint Petersburg, Russia, 197022
        • Local Institution - 0209
      • Saint Petersburg, Russia, 197758
        • Local Institution - 0136
      • Singapore, Singapore, 119228
        • Local Institution - 0218
    • Central Singapore
      • Singapore, Central Singapore, Singapore, 168583
        • Local Institution - 0219
      • Seoul, South Korea, 120-752
        • Local Institution - 0176
    • Seoul
      • Songpa-gu, Seoul, South Korea, 05505
        • Local Institution - 0175
      • Barcelona, Spain, 08035
        • Local Institution - 0078
      • Córdoba, Spain, 14004
        • Local Institution - 0079
      • Madrid, Spain, 28007
        • Local Institution - 0080
      • Madrid, Spain, 28050
        • Local Institution - 0077
      • Basel, Switzerland, 4031
        • Local Institution - 0018
      • Sankt Gallen, Switzerland, 9007
        • Local Institution - 0047
      • Taichung, Taiwan, 40447
        • Local Institution - 0177
      • Tainan, Taiwan, 70403
        • Local Institution - 0178
      • Taipei, Taiwan, 100
        • Local Institution - 0179
      • Adana, Turkey (Türkiye), 01250
        • Local Institution - 0160
      • Erzurum, Turkey (Türkiye), 25240
        • Local Institution - 0161
      • Istanbul, Turkey (Türkiye), 34300
        • Local Institution - 0157
      • Cardiff, United Kingdom, CF14 2TL
        • Local Institution - 0243
      • London, United Kingdom, SE1 9RT
        • Local Institution - 0202
    • Greater London
      • London, Greater London, United Kingdom, SW3 6JJ
        • Local Institution - 0045
      • London, Greater London, United Kingdom, NW1 2PG
        • Local Institution - 0203
    • Hampshire
      • Southampton, Hampshire, United Kingdom, SO16 6YD
        • Local Institution - 0046
    • Manchester
      • Withington, Manchester, United Kingdom, M20 4BX
        • Local Institution - 0049
    • Surrey
      • Sutton, Surrey, United Kingdom, SM2 5PT
        • Local Institution - 0169
    • Arizona
      • Tucson, Arizona, United States, 85711
        • Local Institution - 0250
    • California
      • Los Angeles, California, United States, 90033
        • Local Institution - 0026
      • San Francisco, California, United States, 94158
        • Local Institution - 0068
      • San Francisco, California, United States, 94115
        • Local Institution - 0023
    • Colorado
      • Aurora, Colorado, United States, 80045
        • Local Institution - 0151
      • Denver, Colorado, United States, 80218
        • Local Institution - 0247
    • District of Columbia
      • Washington D.C., District of Columbia, United States, 20007
        • Local Institution - 0054
    • Florida
      • Fort Myers, Florida, United States, 33901
        • Local Institution - 0113
      • Jacksonville, Florida, United States, 32256
        • Local Institution - 0131
      • Miami, Florida, United States, 33136
        • Local Institution - 0226
      • Pensacola, Florida, United States, 32504
        • Local Institution - 0022
      • St. Petersburg, Florida, United States, 33705
        • Local Institution - 0114
    • Illinois
      • Chicago, Illinois, United States, 60637
        • Local Institution - 0153
    • Maryland
      • Baltimore, Maryland, United States, 21202
        • Local Institution - 0025
    • Massachusetts
      • Boston, Massachusetts, United States, 02215
        • Local Institution - 0170
      • Boston, Massachusetts, United States, 02215
        • Local Institution - 0171
      • Boston, Massachusetts, United States, 02215
        • Local Institution - 0055
      • Boston, Massachusetts, United States, 02215
        • Local Institution - 0217
    • Missouri
      • St Louis, Missouri, United States, 63110
        • Local Institution - 0027
    • New Jersey
      • Hackensack, New Jersey, United States, 07601
        • Local Institution - 0058
      • Neptune City, New Jersey, United States, 07753
        • Local Institution - 0066
    • New York
      • New York, New York, United States, 10016
        • Local Institution - 0032
      • The Bronx, New York, United States, 10461
        • Local Institution - 0205
    • North Carolina
      • Charlotte, North Carolina, United States, 28262
        • Local Institution - 0033
      • Durham, North Carolina, United States, 27710
        • Local Institution - 0024
    • Ohio
      • Cleveland, Ohio, United States, 44106
        • Local Institution - 0056
    • Oregon
      • Portland, Oregon, United States, 97239
        • Local Institution - 0165
    • Pennsylvania
      • Allentown, Pennsylvania, United States, 18103
        • Local Institution - 0101
      • Philadelphia, Pennsylvania, United States, 19111
        • Local Institution - 0048
      • Pittsburgh, Pennsylvania, United States, 15212
        • Local Institution - 0116
    • Tennessee
      • Nashville, Tennessee, United States, 37203
        • Local Institution - 0111
      • Nashville, Tennessee, United States, 37232
        • Local Institution - 0130
    • Texas
      • Dallas, Texas, United States, 75216
        • Local Institution - 0216
      • Dallas, Texas, United States, 75246
        • Local Institution - 0248
      • Houston, Texas, United States, 77030-4009
        • Local Institution - 0012
    • Washington
      • Seattle, Washington, United States, 98101
        • Local Institution - 0241
      • Seattle, Washington, United States, 98109
        • Local Institution - 0067
    • Wisconsin
      • Madison, Wisconsin, United States, 53792
        • Local Institution - 0069

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Diagnosed with Stage II/III carcinoma of the esophagus or gastroesophageal junction
  • Completed pre-operative chemo radiotherapy followed by surgery
  • Diagnosed with residual pathologic disease after being surgically rendered free of disease with negative margins following complete resection

Exclusion Criteria:

  • Diagnosed with cervical esophageal carcinoma
  • Diagnosed with Stage IV resectable disease
  • Did not receive concurrent chemoradiotherapy prior to surgery
  • Participants who have received a live/attenuated vaccine within 30 days of the first treatment

Other protocol defined Inclusion/exclusion criteria could apply

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo
Specified dose on specified days
Experimental: Nivolumab
Specified dose on specified days

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disease-free Survival (DFS)
Time Frame: From randomization to the date of recurrence or death (up to approximately 46 months)

Disease-free survival is defined as the time between randomization date and first date of recurrence or death, whichever occurs first.

Recurrence is defined as the appearance of one or more new lesions, which can be local, regional, or distant in location from the primary resected site ( assessed by imaging or pathology). All deaths without prior recurrence are considered as DFS events. For participants who remained alive and without recurrence, DFS was censured on the date of last evaluable disease assessment

From randomization to the date of recurrence or death (up to approximately 46 months)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall Survival (OS)
Time Frame: From randomization to the date of death (up to approximately 60 months)
Overall survival is defined as the time from randomization to the date of death from any cause. For subjects that are alive, their survival time was censored at the date of last contact date (or "last known alive date"). Overall survival was censored at the date of randomization for subjects who were randomized but had no follow-up.
From randomization to the date of death (up to approximately 60 months)
Overall Survival Rates at 12-, 24-, and 36-months
Time Frame: At 12-, 24- and 36-months post first dose.
Overall survival rate is defined as the percentage of participants who are alive at 1, 2 and 3 years following randomization
At 12-, 24- and 36-months post first dose.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Bristol-Myers Squibb, Bristol-Myers Squibb

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 14, 2016

Primary Completion (Actual)

May 12, 2020

Study Completion (Actual)

November 7, 2024

Study Registration Dates

First Submitted

April 15, 2016

First Submitted That Met QC Criteria

April 18, 2016

First Posted (Estimated)

April 19, 2016

Study Record Updates

Last Update Posted (Estimated)

November 18, 2025

Last Update Submitted That Met QC Criteria

November 4, 2025

Last Verified

November 1, 2025

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Advanced Cancer

Clinical Trials on Placebo

Subscribe